Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 10, 2022

View Archived Issues

TMID enzymes as potential antiviral targets for the treatment of HHV infections

Researchers improve cisplatin-induced ototoxicity model

Anti-VISTA HMBD-002 antibody blocks VISTA-induced immunosuppression in preclinical models

Chinese researchers identify new CRBN modulators

Eccogene divulges new GLP-1R agonists

Reaction Biology presents new HDAC inhibitors

Challenge Bioproducts synthesizes new PTGER4 ligands

Customization of regulatory elements in hearing loss gene therapies using AAVAnc80 vectors

Zp Spv 3 K/S describes complement C3 inhibitors

Advanced prostate cancer antibody successful in dogs

Researchers unveil new miRNAs tied to cerebral cavernous angioma

PNV-5032 reduces airflow resistance by 25% in animal test of allergen-induced asthma

Akso and Huadong Medicine sign collaborative agreement for AB-002 in Asia Pacific region

Investigators find a role for miR-206 in intracerebral hemorrhage

JR-14a shows potent neuroprotective effect in stroke models

Popular Stories

Today's news in brief
BioWorld
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 17, 2026
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...